November 07, 2025 a 03:43 pm
CRL: Fundamental Ratio Analysis - Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. provides comprehensive drug discovery and development services on a global scale. The company's diverse services cater to various research needs, ensuring robust support for pharmaceutical and biotech advancements. Although fundamental ratios show average performance, CRL demonstrates potential for strategic growth in its sector.
Fundamental Rating
The fundamental analysis of CRL suggests a moderate outlook with room for improvement. Below are the key scores evaluating different financial aspects.
| Category | Score | Visualization |
|---|---|---|
| Overall | 2 | |
| Discounted Cash Flow | 4 | |
| Return on Equity | 1 | |
| Return on Assets | 1 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 3 |
Historical Rating
An analysis of the historical performance reveals consistency in certain areas while highlighting areas of improvement.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-11-06 | 2 | 4 | 1 | 1 | 1 | 1 | 3 |
| N/A | 0 | 4 | 1 | 1 | 1 | 1 | 3 |
Analysts' Price Targets
The price targets set by analysts show a positive sentiment, suggesting a potential growth trajectory for CRL.
| High | Low | Median | Consensus |
|---|---|---|---|
| 200 | 174 | 195 | 191 |
Analysts' Sentiment
Generally positive, the analyst sentiment highlights CRL as a potential buy, with a notable portion remaining neutral or cautious.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 1 | |
| Buy | 23 | |
| Hold | 12 | |
| Sell | 0 | |
| Strong Sell | 0 |
Conclusion
Charles River Laboratories International, Inc. exhibits a moderate fundamental rating, indicating potential growth areas, particularly in discounted cash flow. Analysts' targets suggest an upward trend, supported by a predominantly buy sentiment. However, ongoing financial strategies and market dynamics will be crucial for improved scores. The company's engagement in a rapidly evolving sector poses both opportunities and challenges that could impact future performance.